Federated Hermes, Inc. Sarepta Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43 Billion
Q4 2024

A detailed history of Federated Hermes, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 380,418 shares of SRPT stock, worth $41.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

380,418

Previous 508,836 25.24%

Holding current value

$41.8 Million

Previous $63.6 Million 27.22%

% of portfolio

0.11%

Previous 0.15%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$104.54 - $137.94 $13.4 Million - $17.7 Million	-128,418 Reduced 25.24%	380,418 $46.3 Million
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $63,035 - $79,472	507 Added 0.1%	508,836 $63.6 Million
Q2 2024 Aug 08, 2024	SELL	$113.33 - $163.85 $11.5 Million - $16.7 Million	-101,887 Reduced 16.7%	508,329 $80.3 Million
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $9.2 Million - $13.9 Million	-98,174 Reduced 13.86%	610,216 $79 Million
Q4 2023 Jan 31, 2024	SELL	$67.31 - $124.76 $17.1 Million - $31.8 Million	-254,659 Reduced 26.44%	708,390 $68.3 Million
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $194,545 - $234,573	-1,898 Reduced 0.2%	963,049 $117 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $15.7 Million - $23.3 Million	148,025 Added 18.12%	964,947 $111 Million
Q1 2023 May 08, 2023	BUY	$117.53 - $155.99 $4.4 Million - $5.85 Million	37,479 Added 4.81%	816,922 $113 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $460,829 - $603,701	4,569 Added 0.59%	779,443 $101 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $5.36 Million - $8.44 Million	70,774 Added 10.05%	774,874 $85.7 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $32,410 - $45,723	517 Added 0.07%	704,100 $52.8 Million
Q1 2022 May 13, 2022	BUY	$63.15 - $90.42 $1.55 Million - $2.23 Million	24,609 Added 3.62%	703,583 $55 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $27.1 Million - $34.8 Million	350,033 Added 106.41%	678,974 $61.1 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $6.79 Million - $9.51 Million	102,858 Added 45.5%	328,941 $30.4 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $3.85 Million - $4.81 Million	-55,452 Reduced 19.7%	226,083 $17.6 Million
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $172,749 - $403,959	-2,391 Reduced 0.84%	281,535 $21 Million
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $3.12 Million - $4.44 Million	-24,867 Reduced 8.05%	283,926 $48.4 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $10.8 Million - $14.6 Million	85,003 Added 37.98%	308,793 $43.4 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $2.33 Million - $4.31 Million	25,086 Added 12.62%	223,790 $35.9 Million
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $8.02 Million - $12.8 Million	97,326 Added 96.0%	198,704 $19.4 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $7.76 Million - $13.7 Million	101,378 New	101,378 $13.1 Million
Q1 2019 May 10, 2019	SELL	$106.67 - $151.68 $2,773 - $3,943	-26 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$97.32 - $148.76 $916,267 - $1.4 Million	-9,415 Reduced 99.72%	26 $2,000
Q3 2018 Nov 13, 2018	SELL	$115.31 - $161.51 $1.18 Million - $1.66 Million	-10,270 Reduced 52.1%	9,441 $1.53 Million
Q2 2018 Aug 10, 2018	SELL	$71.74 - $153.69 $2.41 Million - $5.17 Million	-33,658 Reduced 63.07%	19,711 $2.61 Million
Q1 2018 May 09, 2018	BUY	$54.02 - $82.27 $240,929 - $366,924	4,460 Added 9.12%	53,369 $3.95 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $2.33 Million - $2.78 Million	48,909	48,909 $0

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

85.7M

Call Options Held

1.74M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.62B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Sarepta Therapeutics, Inc. Transaction History